In ovarian cancer, circITGB6 directly interacts with IGF2BP2 and FGF9 mRNA, stabilizing FGF9 mRNA and inducing TAM polarization towards the M2 phenotype, increasing ovarian cancer’s resistance to cisplatin594 (Fig. 5). Here, FGF9 is linked to ovarian cancer.